Picard Medical wins NYSE American approval of plan to regain listing compliance

• NYSE American accepted Picard Medical’s plan to regain compliance with continued listing standards under Sections 1003(a)(i) and (ii).
• Decision keeps the stock listed on NYSE American under PMI while the company executes its remediation plan.
• Compliance window runs through Nov. 8, 2027, subject to periodic exchange review and ongoing adherence to other listing standards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270700PRIMZONEFULLFEED9768029) on July 27, 2026, and is solely responsible for the information contained therein.